Merit

For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Healing & Recovery

KPV

Also known as: Lysine-Proline-Valine (alpha-MSH 11-13)

KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone (alpha-MSH), corresponding to residues 11-13. It is the smallest alpha-MSH fragment shown to retain anti-inflammatory activity. Research-only; not FDA-approved; evidence is primarily preclinical.

Real-time market data

Pricing for KPV

Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.

Average price

$6.54/mg

range $0.56–$44.99/mg

Sellers

74

from $0.00

45-day trend

-25.9%

vs 45-day avg $/mg

61 of 74 sellers have a current price· 12 stale listings hidden (not seen in 7 days)

Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.

Independent evidence

COAs for KPV

126 third-party tests across 28 vendors. Each card links to the full report.

All 126 COAs for KPV →
Measured purity 97.8%–100.0% across 84 COAs
Measured purity over time
Aggregated · 3rd-party listing
98.16 %
Jun 2026
Janoshik Analytical Limited

For

KPV

by Optima Supply· batch OS-2026-1179

Aggregated · 3rd-party listing
98.16 %
Jun 2026
Janoshik Analytical Limited

For

KPV

by Hydro Research Peptides· batch HR-2026-4981

Aggregated · 3rd-party listing
99.60 %
Jun 2026
Freedom Diagnostics Moderate

For

KPV

by Apexx Biolabs· batch Purple Cap-1

Aggregated · 3rd-party listing
99.71 %
Jun 2026
ILS Labs Strong

For

KPV

by Mile High Compounds· batch KPV-010-MH-05

✓ Vendor-published
99.39 %
Jun 2026
TrustPointe Analytics Moderate

For

KPV

by Peptide Partners· batch SPL-4157

COA on file
✓ Vendor-published
99.70 %
Jun 2026
Kovera Labs

For

KPV

by Peptide Partners· batch KV202606

COA on file
Aggregated · 3rd-party listing
99.19 %
Jun 2026
ILS Labs Strong

For

KPV

by Crush Research· batch CR-KPV-10-2605-1

Aggregated · 3rd-party listing
99.80 %
May 2026
Vanguard Laboratory Strong

For

KPV

by Moglabs· batch KPV002

Aggregated · 3rd-party listing
99.18 %
May 2026
Janoshik Analytical Limited

For

KPV

by EZ Peptides· batch EZP-KPV1005152026-12

✓ Vendor-published
99.18 %
May 2026
Janoshik Analytical Limited

For

KPV

by EZ Peptides· batch EZP-KPV1005152026-12

COA on file
Aggregated · 3rd-party listing
99.33 %
May 2026
Freedom Diagnostics Moderate

For

KPV

by Nox Amino· batch NA-KP0526-01

Aggregated · 3rd-party listing
99.28 %
May 2026
Horizon Analytical

For

KPV

by Blank Peptides· batch BP-4451178-P

Aggregated · 3rd-party listing
99.72 %
May 2026
ILS Labs Strong

For

KPV

by NG Peptide· batch KP10-05

Aggregated · 3rd-party listing
98.90 %
May 2026
MZ Biolabs Moderate

For

KPV

by Kimera Chems· batch KC-KPV-03

Aggregated · 3rd-party listing
99.21 %
May 2026
ILS Labs Strong · HPLC

For

KPV

by Glacier Aminos· batch KPV10GA-03

Aggregated · 3rd-party listing
99.22 %
May 2026
Freedom Diagnostics Moderate

For

KPV

by Real Peptides· batch Black Cap

Aggregated · 3rd-party listing
99.36 %
Apr 2026
ILS Labs Strong · HPLC

For

KPV

by Crush Research· batch CRKPV-10-2604-1

Aggregated · 3rd-party listing
99.29 %
Apr 2026
ILS Labs Strong

For

KPV

by Riptide Wellness· batch RWKPV-10-1003

Aggregated · 3rd-party listing
99.14 %
Apr 2026
ILS Labs Strong

For

KPV

by Sunrise Bioresearch· batch KPV10APR2026

✓ Vendor-published
99.14 %
Apr 2026
ILS Laboratories

For

KPV

by Sunrise Bioresearch· batch KPV10APR2026

COA on file
Aggregated · 3rd-party listing
99.71 %
Apr 2026
Janoshik Analytical Limited

For

KPV

by EZ Peptides· batch EZP-KPV1004082026-11

Aggregated · 3rd-party listing
99.00 %
Apr 2026
Ethos Analytics Strong · HPLC

For

KPV

by OROS Research· batch OR-LPKPV15-426-B2

Aggregated · 3rd-party listing
99.72 %
Apr 2026
Freedom Diagnostics Moderate · HPLC

For

KPV

by Peptide Plugs· batch 112-U-A

Aggregated · 3rd-party listing
99.60 %
Apr 2026
Janoshik Analytical Limited · HPLC

For

KPV

by Verified Peptides· batch cmp4wgc1s004px7rxyjbwbykv

Research depth

12 citations indexed for KPV

All research on KPV →

Study · 2026

Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the PPARγ pathway in HepG2 cells

Hepatocellular steatosis, an early stage within the non-alcoholic fatty liver disease (NAFLD) spectrum, is characterized by excessive lipid accumulation and oxidative stress in hepatocytes.

in-vitro · 2026

Exploration of 1,3,4-Thiadiazole Bearing Quinolin-2(1H)-One Hybrids as Potent Antimycobacterial Agents: Design, Synthesis, and In Silico Docking Techniques

Introduction The development of novel quinolin-2(1H)-one-fused 1,3,4-thiadiazole heterocyclic hybrids was achieved through structural optimization as potential antimicrobial/anti- TB agents.

Study · 2026

Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers

Oral delivery of peptide therapeutics remains challenging due to gastrointestinal (GI) degradation and poor intestinal absorption.

Study · 2026

Pediatric Neuroinflammatory and Neuropsychiatric Syndromes Associated with Dupilumab Treatment for Atopic Dermatitis

Dupilumab, a monoclonal antibody blocking interleukin-4/interleukin-13 signaling, was associated with neuroinflammatory syndromes in 4 children treated for atopic dermatitis. Individuals exhibited behavioral changes, language impairment, and neurodiagnostic abnormalities 2-6 months after treatment initiation.

review · 2026

Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives

Therapeutic peptides are short chains of amino acids used to treat metabolic and endocrine conditions such as obesity and type 2 diabetes.

Study · 2026

NLRP3 autophagic degradation disruption in melanocytes contributes to vitiligo development

NLRP3 functions as a critical intracellular danger sensor for inflammasome activation, playing a crucial role in autoimmune diseases. Vitiligo progression has been linked to NLRP3, yet its specific involvement in melanocytes of vitiligo remains poorly understood.